+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study



Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study



Virchows Archiv. A Pathological Anatomy and Histopathology 414(2): 179-185



The pancreases of 23 patients (mean age 10.5 years, range 5-22) years dying of cystic fibrosis (CF) were evaluated at autopsy by routine histology and immunostaining for changes in their endocrine cell compartment. The severely altered pancreatic tissues showed end stage CF, with either a fibrotic pattern (CF-FIB, n = 14) or a lipoatrophic pattern (CF-LIP, n = 9) prevailing. In all specimens, irrespective of the dominating pattern, the islet system was affected by marked periinsular and intrainsular sclerosis. Quantitatively, the volume densities (relative tissue components) of the parenchymal, fibrotic, fatty and total endocrine compartments as well as the four islet cell types (B, A, D, PP) were determined by point counting. Compared with controls, the CF patients (including two patients with overt diabetes and glucose intolerance, respectively) had a significantly decreased insulin (B)-cell ratio (from 64.4 to 34%) with a concomitant rise in non-B-cells (A-cells: 23.2 to 35%; D-cells: 10.4 to 22%; PP-cells; 2 to 9%). Comparison of endocrine cell ratios in CF-FIB pancreases with CF-LIP pancreases revealed no significant differences. The reduction of approximately 50% of insulin cells in CF patients with advanced disease supports the concept that destruction of exocrine tissue with concomitant fibrous disorganization of islets gradually changes the proportional distribution of the endocrine cells in favor of the noninsulin cells. This slowly ongoing process probably provides the basis for islet dysfunction, i.e. diabetes, increasingly observed in final stage CF.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039727382

Download citation: RISBibTeXText

PMID: 2492695


Related references

Cystic fibrosis associated islet changes may provide a basis for diabetes. Virchows Archiv 414(2): 179-185, 1989

Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatric Pulmonology 32(5): 343-350, 2001

Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. Journal of Clinical Endocrinology and Metabolism 81(3): 1267-1272, 1996

Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study. Diabetologia 54(12): 3007-3015, 2011

Cystic fibrosis-related diabetes is caused by islet loss and inflammation. Jci Insight 3(8):, 2018

Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. Journal of Pediatric Endocrinology and Metabolism 13(3): 319-324, 2000

Islet-after-lung transplantation in a patient with cystic fibrosis-related diabetes. Diabetes Care 37(7): E159-E160, 2014

Pediatric Case Series of Cystic Fibrosis, Diabetes, and Islet Cell Autoimmunity. Clinical Diabetes 36(4): 331-333, 2018

Combined Pancreatic Islet-Lung-Liver Transplantation in a Pediatric Patient with Cystic Fibrosis-Related Diabetes. Hormone Research in Paediatrics 90(4): 270-274, 2018

Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress. Antioxidants and Redox Signaling 9(7): 891-910, 2007

An immunocytochemical study of IL-8 and heparan sulphate expression in the lung in cystic fibrosis. European Respiratory Journal 8(Suppl. 19): 576S, 1995

Combined pancreatic islet-lung transplantation with islet percutaneous portal embolization in cystic fibrosis. Transplantation 85(11): 1670-1671, 2008

Morphologic and immunocytochemical study of young dogs with diabetes mellitus associated with pancreatic islet hypoplasia. American Journal of Veterinary Research 49(9): 1577-1581, 1988

Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium. Bmj Open Diabetes Research and Care 4(1): E000183, 2016

Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation. Journal of Cystic Fibrosis 5(1): 67-68, 2006